Mnemo Therapeutics

Recent Finacing

Series A

Recent Raise

$91M

Mnemo Therapeutics develops CAR T cell therapies using its EnfiniT discovery engine to identify novel tumor antigens and engineer T cells with enhanced memory phenotype and target specificity.

Founded 2019

Ile-de-France, France

51-100

Private

mnemo-tx.com

Highlights

Focus Areas

Biotechnology

Recent Investors

Financials

$91M

Total Raised

1

Funding round

5

Investors

Team

Upgrade to view the team

See the team members at Mnemo Therapeutics.